New programme to train future mental health and neuroscience professionals
Future healthcare professionals working in mental health and neurosciences will be trained at a new Doctoral Training Programme (DTP) thanks to a multi-million award from Wellcome.
Led by the Univ…
New drug treatment regimen shows promise for patients with lupus
The results of a randomised controlled trial, published in Annals of Internal Medicine, found that a new drug treatment regimen – using belimumab soon after rituximab – reduced a disease-related au…
Contraceptive pill can reduce type 2 diabetes risk in women with polycystic ovary syndrome
A study led by BHP founder-member the University of Birmingham has revealed for the first time that the contraceptive pill can reduce the risk of type 2 diabetes by over a quarter in women with pol…
Specific cell population plays key role in effect of arthritis and people’s pain
Research led by scientists at BHP founder-member the University of Birmingham has identified a new specific population of cells that plays a key role in the affect arthritis has on the body and the…
Triple-drug combo could prove key weapon in fight against cancer
Combining three existing drugs – a commonly-used anti-epileptic, a contraceptive steroid and a cholesterol-lowering agent – could form an effective and non-toxic treatment for a range of aggressive…
Artificial Intelligence project aims to improve diversity and equality in AI systems
A new project has been launched across BHP members, aiming to address racial and ethical health inequalities using artificial intelligence (AI).
STANDING Together, being led by BHP founding member…